Skip to main content
. 2018 Nov 9;30(3):266–270. doi: 10.5152/tjg.2018.18559

Table 2.

ALT levels in patients with type 2 diabetes mellitus in relation to transient elastography-defined hepatic fibrosis and steatosis

Severity of fibrosis
No F3/4 ≥F3 F4
ALT, U/L 21 (17–29) 39 (23–50) 24 (19–35)
Severity of steatosis
None Moderate Severe
ALT, U/L 19 (15–30) 31 (22–47) 34 (20–54)